Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies

View source ↗

Summary

The study aims to characterize the longitudinal prognosis of lymphoproliferative manifestations in patients with primary immunodeficiencies. It is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Primary Immune Deficiencies, Benign Lymphoproliferative Disorder | Status: NOT_YET_RECRUITING